|
Market Report
|
Disease Modification in Rheumatoid Arthritis - New drug targets compete in crowded market
Drugs with new mechanisms, in particular Pfizer's oral JAK inhibitor CP-690,550 and Chugai/Roche's Actemra (tocilizumab), will launch for rheumatoid arthritis and should offer advantages over current therapies, but do not come without some safety signals. Late-stage pipeline launches will be a major contributor to market growth from $7.4 billion in 2008 to $11.5 billion in 2018.
|
|
Read more...
|
|
|
Market Report
|
Pain Market Overview - Non-traditional analgesics and opioid reformulations to sustain sector growth
The mature pain market has experienced a turbulent 4-year period during which the estimated seven major market sales value has fallen from an all-time high in 2004 down to $24.29 billion in 2007. However, through the growing use of non-traditional analgesics and the emergence of a number of opioid reformulations, the market is set to consolidate in a new phase of growth and prosperity.
|
|
Read more...
|
|
|
Market Report
|
The Pain Management Market Outlook To 2014: Competitive landscape, pipeline analysis and growth opportunities
This report provides comprehensive coverage of major markets within the global pain management area, incorporating a epidemiological analysis of key neuropathic and nociceptive pain indications and the main factors impacting their prevalence. This report reviews the factors and underlying trends that are shaping the pain management market and identifies areas of potential growth.
|
|
Read more...
|
|
|
Market Report
|
Neuropathic Pain - Brighter future for pipeline drugs while current brands downgraded
Datamonitor forecasts the neuropathic pain market to more than double in value from 2008 to total $5.2 billion by 2018 across the seven major markets (US, Japan, and the 5EU [France, Germany, Italy, Spain and the UK]). Although the US will provide the greatest increase in value over this period, Japan and the 5EU markets will post double-digit compound annual growth rates.
|
|
Read more...
|
|
|
Market Report
|
Stakeholder Insight: Osteoarthritis - Drug development lags behind rising osteoarthritis population
Datamonitor expect osteoarthritis prevalence to grow by over 10 million by 2020, owing mainly to an aging population. In the near-term the approach to treatment will remain constant, with improved side-effects dominating the unmet needs. However, therapies which target the underlying causes of osteoarthritis have the potential to reshape osteoarthritis treatment.
|
|
Read more...
|
|
|
Market Report
|
Stakeholder Opinions: Back Pain - Gain competitive edge by targeting subpopulations
Back pain can restrict activity and quality of everyday life and in some cases is a potentially chronic and even crippling condition. Therefore, back pain exerts a large economic impact on society. Due to the high prevalence of back pain, Datamonitor believes that the condition represents a commercially attractive target to pharmaceutical companies with an interest in the pain market.
|
|
Read more...
|
|
|
Market Report
|
Medical Imaging - Global Displays and Post-Processing Software Market (2009 -2014)
Rising healthcare costs and the increasing demand for healthcare services have effected a significant transformation in the field of healthcare image management software over the last decade. Healthcare equipment vendors are now seeking to provide an integrated diagnostic model facilitating patient-centric, evidence-based healthcare. The major features of post-processing include workflow tasks such as image processing, image reconstruction, computer-aided detection, three-dimensional (3D) view generation, and quality control.
|
|
Read more...
|
|
|
Market Report
|
US and European Ultrasound Systems Market: Increasing Demand to Drive Growth
GlobalData, the industry analysis specialists' new report, "US and European Ultrasound Systems Market: Increasing Demand to Drive Growth", finds that an aging population growth coupled with cost-effectiveness and advancements in technology are expected to drive growth in the US and Europe ultrasound systems market. The report highlights these factors as the key drivers for the US and Europe ultrasound systems market.
|
|
Read more...
|
|
|
Market Report
|
Global Hip And Knee Implants Market: Market Penetration to Drive Growth
GlobalData, the industry analysis specialists' new report, "Global Hip and Knee Implants: Market Penetration to Drive Growth" finds that an increasing incidence of osteoarthritis in the aging population pool will drive growth of hip and knee implants market, globally. An increasing aging population and innovative product offerings are expected to drive revenue growth and investor interests in the global hip and knee implants markets.
|
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 37 - 45 of 366 |
Farmavita.Net Journal 
